Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

liver cirrhosis/triglyceride

Lyen an sove nan clipboard la
Paj 1 soti nan 511 rezilta yo
Metabolic disorders are characterized by pathologies like visceral adiposity, hypertension, type 2 diabetes mellitus (T2DM), dyslipidemia, impaired glucose tolerance, fatty liver, and so on, with insulin resistance being the main contributing factor. Insulin resistance and diabetes mellitus are
BACKGROUND Elevated fasting triglyceride is often associated with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. On the other hand, as liver disease progresses, patients may develop hepatocellular dysfunction that impairs triglyceride
OBJECTIVE This study investigated whether splenectomy is of significance in non-alcoholic steatohepatitis (NASH). METHODS Five-week-old Wistar rats were fed a choline-deficient diet for 8 weeks to create a NASH model. A sham-operation or splenectomy was then performed, and rats were killed 4 weeks
Background: The triglyceride-glucose index (TyG) is a reliable predictor of non-alcoholic fatty liver disease (NAFLD). Its association with the severity of hepatic steatosis and liver fibrosis in NAFLD is poorly understood. This study

[Serum triglycerides in liver cirrhosis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Metabolism of triglycerides in liver cirrhosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Hepatic cirrhosis; correlation of clinical severity and abnormality in triglyceride metabolism.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

[Chylous ascites associated with liver cirrhosis treated with medium-chain triglycerides].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

[Fatty acid and triglyceride turnover in patients with liver cirrhosis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

[Triglyceride metabolism in cirrhosis of the liver (author's transl)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
OBJECTIVE To investigate the impact of low skeletal muscle mass (LSMM) on survival as compared with protein-energy malnutrition (PEM) in patients with liver cirrhosis (LC). METHODS A total of 206 individuals with LC were analyzed. We retrospectively examined the impact of LSMM, as defined by psoas

Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND Liver fibrosis is chronic liver damage usually caused by alcohol, viruses or other toxins and is characterised by an excessive accumulation of extracellular matrix proteins such as collagen. The aim of this study was to establish an animal model of chronic liver damage and investigate
During the development of liver fibrosis in rats by an individual dose-titrated CCl4 administration, hepatic proton spin-lattice relaxation time (T1) has been measured in vivo every 2 weeks for 8 weeks. Liver content of collagen, triglycerides and water has been measured biochemically in biopsy

Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
OBJECTIVE Accurate assessment of cirrhotic patient's prognosis is essential for decisions regarding the course of treatment. Therefore we aimed to confirm and quantify the predictive value of serum cholesterol and serum triglycerides in liver cirrhosis patients. METHODS We performed a retrospective
Antre nan paj
facebook nou an

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

  • Travay nan 55 lang
  • Geri èrbal te apiye nan syans
  • Remèd fèy rekonesans pa imaj
  • Kat entèaktif GPS - tag zèb sou kote (vini byento)
  • Li piblikasyon syantifik ki gen rapò ak rechèch ou an
  • Search remèd fèy medsin pa efè yo
  • Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

Google Play badgeApp Store badge